The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksELX.L Regulatory News (ELX)

  • There is currently no data for ELX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Scheme of Reconstruction

2 Jul 2019 09:00

RNS Number : 1666E
El Oro Ltd
02 July 2019
 

2 July 2019

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA OR THE REPUBLIC OF SOUTH AFRICA

El Oro Ltd

Result of Scheme of Reconstruction

In relation to the recommended proposals for the voluntary winding-up and reconstruction of El Oro Ltd (the "Company") as set out in the circular published by the Company dated 24 May 2019 (the "Circular"), the Company announces the following.

Further to the approval of the resolutions to put the Company into voluntary liquidation which were proposed and duly passed on 20 June 2019, Nick Vermeulen and Christiaan Van Den Berg, both of PricewaterhouseCoopers CI LLP of Royal Bank Place, 1 Glategny Esplanade, St Peter Port, Guernsey, GY1 4ND have been appointed as liquidators.

Application has been made to the TISEA and the London Stock Exchange for the listing of the Reclassified Shares on the premium segment of the Official List and for trading on the SETSqx trading platform respectively to be cancelled at 7.00 a.m. on 22 July 2019.

Residual Value

On the Calculation Date the unaudited net asset value of the Company was £46,215,013.27 (calculated on a bid basis and providing for the estimated expenses of the winding up of the Company of £440,000, the value of the Illiquid Assets of £1,142,692.69 which will be retained in the Liquidation Fund and a retention for the Liquidation Fund of £500,000). On this basis, the Residual Value of an El Oro Share as at Thursday 27 June 2019 was £0.70959893 per Share.

Accordingly, and based on the elections and deemed elections, the aggregate value attributable to each of the Rollover Funds and to the Cash Option are as follows:

JPMorgan Elect Managed Growth Shares

£5,888,812.67

JPMorgan Elect Managed Income Shares

£19,480,689.52

JPMorgan Elect Managed Cash Shares

£805,188.04

Cash Option

£18,397,142.28

 Issue Prices

The JPMorgan Elect Issue Prices calculated as at 27 June 2019 were as follows:

JPMorgan Elect Managed Growth Shares (p)

870.92

JPMorgan Elect Managed Income Shares (p)

110.69

JPMorgan Elect Managed Cash Shares (p)

104.03

 

 

Settlement of Elections made by Shareholders will be as set out in the Circular with cheques expected to be despatched and CREST payments made to Shareholders in respect of the Cash Option on or as soon as practicable after 3 July 2019 and share certificates for JPMorgan Elect Securities issued under the Scheme expected to be despatched in the week commencing 15 July 2019.

 

 

Distributions from the Liquidation Fund

 

To the extent that any part of the Liquidation Fund is not required to meet the Company's liabilities or the liabilities of the UK Subsidiaries, including the net proceeds of sale of any of the Illiquid Assets, the balance remaining in the hands of the Liquidators will be paid as one or more liquidation distributions to Shareholders who are on the Company's register of members as at the close of business on the Scheme Effective Date on a pari passu basis pro rata to their respective holdings of Shares, provided that if any such amount otherwise payable to a Shareholder is less than £5.00, it will not be paid to such Shareholder but will be transferred by the Liquidators to a charity, Cancer Research UK (Registered Charity Number 1089464) (the Nominated Charity).

 

Shareholders will receive communication(s) from the Liquidators in due course.

Notes

Terms used and not defined in this announcement have the meanings given in the Circular unless the context otherwise requires.

 

For further information:

Liquidator:

Natalie Boes

natalie.boes@pwc.com

07911 163663

 

Nick Vermeulen

nick.vermeulen@pwc.com

01481 752000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLIFVDDIIFIIA
Date   Source Headline
2nd Jul 20199:00 amRNSResult of Scheme of Reconstruction
20th Jun 20193:00 pmRNSResult of EGM
14th Jun 20191:30 pmRNSScheme Timetable Update
14th Jun 201912:00 pmRNSGroup Portfolio List of Investments
24th May 20195:00 pmRNSPublication of Circular
13th May 20196:08 pmRNSNet Asset Value
8th May 201912:00 pmRNSCancellation of Shares
1st May 201912:00 pmRNSUpdate on Proposals
24th Apr 20192:00 pmRNSNet Asset Value
16th Apr 20192:30 pmRNSGroup Portfolio List of Investments
1st Apr 201912:30 pmRNSHalf-year Report
15th Mar 201912:00 pmRNSNet Asset Value
25th Feb 20193:00 pmRNSNet Asset Value(s)
4th Feb 201911:30 amRNSGroup Portfolio List of Investments
20th Dec 20183:30 pmRNSResult of AGM
14th Dec 20183:00 pmRNSNet Asset Value(s)
30th Nov 20183:04 pmRNSNotice of AGM and Proposal
16th Nov 20183:30 pmRNSNet Asset Value(s)
12th Nov 20184:00 pmRNSCancellation of Treasury Shares
15th Oct 20183:30 pmRNSNet Asset Value(s)
3rd Oct 20183:30 pmRNSDividend Declaration
3rd Oct 20183:30 pmRNSAnnual Financial Report
28th Sep 20185:00 pmRNSNet Asset Value(s)
16th Aug 20185:00 pmRNSNet Asset Value(s)
6th Aug 20184:00 pmRNSNet Asset Value(s)
3rd Jul 20184:30 pmRNSNet Asset Value(s)
25th May 20183:00 pmRNSEU GDPR Data Privacy Notice
18th May 20184:00 pmRNSNet Asset Value(s)
20th Apr 20184:30 pmRNSNet Asset Value(s)
19th Mar 20184:00 pmRNSNet Asset Value(s)
15th Mar 201811:45 amRNSHalf-year Report
14th Feb 20184:00 pmRNSNet Asset Value(s)
17th Jan 20183:00 pmRNSNet Asset Value(s)
5th Jan 20184:30 pmRNSDirector/PDMR Shareholding
21st Dec 20173:00 pmRNSKey Information Document
15th Dec 20173:30 pmRNSNet Asset Value(s)
16th Nov 20171:42 pmRNSResult of AGM
16th Nov 201710:00 amRNSNet Asset Value(s)
13th Oct 20173:00 pmRNSNet Asset Value(s)
5th Oct 20173:00 pmRNSNet Asset Value(s)
26th Sep 20175:30 pmRNSNotice of AGM
26th Sep 20175:30 pmRNSAnnual Report & Accounts
26th Sep 20175:30 pmRNSDividend Declaration
11th Aug 20173:00 pmRNSNet Asset Value(s)
27th Jul 20173:00 pmRNSNet Asset Value(s)
19th Jun 20174:00 pmRNSNet Asset Value(s)
26th May 20175:00 pmRNSDirector/PDMR Shareholding
10th May 20173:00 pmRNSNet Asset Value(s)
2nd May 20173:00 pmRNSDirector/PDMR Shareholding
19th Apr 20174:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.